Tom has worked in advisory, investing and operating roles within the healthcare industry for over 20 years, specifically focused on medical products, medical technology and diagnostics companies. Peloton has utilized Tom's expertise in Financial and Operating Strategy to help HealthPlanOne, Inc. evaluate the unit economics of its various revenue streams and refine financial reporting and to assess Identity Theft Guard Solutions, Inc. as an investment opportunity.
Tom has also served as the Chief Financial Officer for AgaMatrix Inc., a Ferrer Freeman & Company ("FFC") portfolio company, since January 2014. Prior to serving as AgaMatrix CFO, from 2011 to 2013 he served as CEO of Angiotech Pharmaceuticals Inc., a global specialty pharmaceutical and medical device company. As CEO, Tom guided Angiotech to significant improvements in operating and financial results, leading to the successful sale of the company's Interventional Products Business in 2013 for over $360 million. Prior to being named CEO in 2011, he served as Angiotech's CFO, and led the company through a period of growth, multiple strategic and financing transactions, and eventually a successful operational restructuring and debt recapitalization. In October 2013, Tom transitioned to Angiotech's Board of Directors, and served as a member of the Operating Committee.
Tom currently serves as a member of the Board of Directors of IZI Medical Products Inc., as well as Chair of the Audit Committee. He has also served as a member of the Board and Chair of the Audit Committee for LifeCare Management Services and OncoGenex Inc. Tom is also a co-founder, member of the Board, and CFO of the Homestretch Foundation, which provides financial, housing and other resources to elite female professional cyclists and triathletes. Prior to joining Angiotech in 2003, Tom worked in investment banking and private equity, most recently as leader of the biotechnology
practice group at Credit Suisse First Boston and DLJ. He received his B.A. from Harvard University, and his M.B.A. from Harvard Business School.
Kevin has worked in operating, advisory and investing roles within the healthcare industry for over 30 years, specifically focused on health insurance companies and related technology and services. Peloton has utilized Kevin's expertise in Sales and Marketing strategy and execution to help Identity Theft Guard Solutions, Inc. execute on the design and go-to-market positioning of a novel medical identity theft and fraud prevention product, among other initiatives.
Kevin also currently serves as Chairman for HealthPlanOne, Inc., a Peloton portfolio company that provides technology-enabled member acquisition and retention services to large health plans, focused primarily on Medicare consumers. Prior to his role as Chairman of HealthPlanOne, Inc., Kevin was CEO of UnitedHealth Group's ("UNH") Northeast Division from 2004 until 2006, where he had full P&L responsibility for UNH's largest region. Prior to working with UnitedHealth Group, from 1989 through 2004, Kevin served in a number of executive management positions at Oxford Health Plans, including as Executive Vice President of Sales, Products and Pricing from 1999 until 2004. During his time at Oxford, Kevin was instrumental in driving revenue growth from less than $20 million in 1989 to approximately $6 billion in 2004, when Oxford was sold to UNH for $4.9 billion.
After leaving UNH in 2006, Kevin has worked extensively in advising and investing in lower middle market healthcare companies with a focus on health plans, outsourced health plan services and benefits administration. He serves or has served on the boards of numerous healthcare companies, including Picwell, Benestream, StatPayMD, Virtual Health and CheckPointHR (Chairman of the Board), among others. He also serves as advisor to Alegeus and served as a Board Observer to Liazon Corporation and TechHealth. He received a B.A. from Rutgers University.
Ted is currently consulting with Peloton and other healthcare investors after spending over 23 years in the clinical laboratory industry, including 15 years with Genova Diagnostics, a former FFC portfolio company. At Genova, Ted served as Chairman and CEO from 2003 through 2015, and prior to that, as COO from 2000 to 2003. As an executive, Ted focused on establishing Organizational Excellence through metric-driven performance initiatives and a company-wide strategic vision. Under his leadership, Genova achieved double-digit organic growth and acquired and integrated its largest competitor, reaching over $100 million in revenue and $30 million in EBITDA before his retirement in 2015.
Following Genova, Ted spent a year as Senior Vice President of Clinical Diagnostic Services U.S. for Eurofins Scientific, one of the global market leaders in agroscience, genomics, discovery pharmacology, and central laboratory services. Prior to Genova, he spent seven years with Quest Diagnostics and Nichols Institute where he held a variety of leadership positions in finance and business development. Before joining Quest, Ted served as a Manager in the Audit group for Deloitte from 1988 to 1993. He received a B.S. from The Wharton School at the University of Pennsylvania.
Keith has worked extensively with the Peloton team in operating, investing and advisory roles since 1998, including helping Peloton assess Arcadia Solutions, LLC and Identity Theft Guard Solutions, Inc. as investment opportunities.
Since 2010, he has been Executive Vice President and Chief Financial Officer of Ernest Health, a leading operator of inpatient rehabilitation facilities and long-term acute care hospitals in tertiary markets of the U.S., and a former FFC portfolio company. In his role at Ernest, Keith has been instrumental in the company's Financial and Operating Strategy, including
developing and executing on the growth plan and leading the company's efforts in capital raising and M&A, including managing Ernest's sale to Medical Properties Trust (NYSE: MPW) for $400 million in 2012.
Prior to joining Ernest Health, from 1998 until 2010, Keith was a Partner at Ferrer Freeman & Company, where he worked on investments such as Amerigroup Corporation, Concentra, Inc./MultiPlan, Inc., Ernest Health, Inc., Omnicell, Inc. and Medical Depot, Inc., among others. Previously, he was a Vice President at JP Morgan. Keith received a B.A. from Boston College and a M.B.A. from the Business School at Columbia University.
Albert has worked in management roles in the information technology industry over the last 25 years, specifically as the executive leader of Technology Vision, Strategy and Execution for a number of healthcare companies. Peloton has leveraged this expertise in its evaluation of HealthPlanOne, Inc. and Identity Theft Guard Solutions, Inc. as investment opportunities
and the ongoing execution of product and service roadmaps for each.
Currently, Albert serves as the Chief Information and Chief Technology Officer for AeroCare Holdings, Inc., a Peloton portfolio company and top 5 U.S. provider of respiratory therapy equipment and services to patients in their homes, a role he has held since 2014. At AeroCare, Albert has focused on implementing licensed and internally-developed technology solutions to enhance efficiency and create a competitive advantage in an industry that has historically relied on paper-based operations. At AeroCare, he has led product development, technology partner business development initiatives, and a strategy to electronically connect AeroCare with its patients and referral sources. Prior to joining AeroCare, he served as an SVP at UnitedHealth Group, as CTO of the Optum Cloud. Prior to working with UnitedHealth, he served as CIO/CTO of Connextions Inc., a company that specialized in consumer driven healthcare solutions for payors, and was sold to Optum (a UnitedHealth Group company) in August of 2011. Before Connextions, Albert was CIO of Rotech Medical Corporation, a publicly traded medical equipment company.
Albert is an active investor in healthcare and technology companies and currently serves on the Board of Directors of NucleusHealth, MetisMachine, HCF Enterprises and HCF Reality. Albert holds a B.A. from the University of Michigan and a M.B.A. from Rollins College.
Leslie chairs Peloton’s Advisory Board and advises Peloton on CMS policy and the health care regulatory environment.
She is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors. Leslie served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) where she managed the day-to-day operations of Medicare, Medicaid, and The State Child Health Insurance Programs, among other federal health care initiatives. Previously, she was the agency's Deputy Administrator, responsible for the implementation of the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.
Leslie serves or has served on the board of directors for numerous healthcare companies, including Peloton portfolio company HealthPlanOne and former FFC portfolio companies, Preferred Care Partners and Volcano Corp.
Richard provides strategic counsel to Peloton, specifically regarding health care practice management, clinical quality initiatives and innovative care delivery models.
Dr. Bohmer, MBChB, MPH, is a New Zealand trained physician that served on the faculty of Harvard Business School (HBS) for 18 years. In 2014, he founded Clinical Leadership Resources, a healthcare consulting and advisory firm focused on reform of healthcare delivery. Prior to joining HBS, he was the Clinical Director of Quality Improvement at Massachusetts General Hospital, where he was responsible for planning and implementing the institution's clinical quality improvement program. He has been named one of the United Kingdom’s Top 100 Most Influential Clinical Leaders for the last three years.
Jim provides strategic counsel to Peloton, specifically regarding health care information technology systems, revenue cycle services and institutional selling and marketing in health care.
Jim joined IDX in 1981 where he spent 25 years in many capacities including as President and Chief Executive Officer. In 2006, he helped orchestrate the sale of IDX to GE Healthcare (NYSE: GE). Prior to IDX, Mr. Crook started his career with IBM (NYSE: IBM).
Jim is currently a member of the Board of Managers at Arcadia Solutions and was a member of the Board of Directors of Vitalize Consulting Solutions, an FFC portfolio company, prior to its sale to SAIC in 2011.
Scott provides strategic counsel to Peloton, specifically regarding medical products, medical technology and diagnostics.
Scott has over 25 years of experience in the medical device, technology and diagnostics sectors, including over 15 as a CEO. He is currently CEO of Verb Surgical, a Google and Johnson & Johnson joint venture focused on building a digital surgery platform that combines robotics, advanced visualization, advanced instrumentation, data analytics and connectivity. He is the former President and CEO of Volcano Corporation, a former FFC portfolio company. In 2006, Volcano went public, and in February of 2015 the company was sold to Royal Philips for $1.2 Billion. Prior to Volcano, he was President and CEO of Digirad Corporation (NASDAQ: DRAD), which went public in 2004.
Scott serves or has served on the boards of numerous healthcare companies and healthcare organizations, including EndoChoice Medical, REVA Medical, Sonendo, and the Medical Device Manufacturer's Association, among others.
Pat provides strategic counsel to Peloton, specifically regarding performance improvement, cost management and supply chain solutions in health care, as well as health care products and services distribution.
Pat joined Press Ganey as CEO in early 2012, a company he took public in 2015 and which was subsequently acquired by EQT in August 2016 for $2.35 billion. Prior to joining Press Ganey, he served as Chairman and Chief Executive Officer of The Broadlane Group until it was acquired by MedAssets (NASDAQ: MDAS) in 2010. Prior to joining The Broadlane Group, he served as Chief Executive Officer and Director of PolyMedica Corporation until its sale to Medco (NYSE: MHS) in 2007. Previously, Pat served as the Chairman and CEO of Physicians Dialysis, a former FFC portfolio company acquired by DaVita (NYSE: DVA) in 2004.